poisar

Stock

Phibro Animal Health Corporation PAHC

$34.06+0.77%

Overview

PAHC market data

Price History

PAHC price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
14.40
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$1.19
Diluted earnings per share over the trailing twelve months.
Beta
0.40
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
1.4%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
6.4%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$28.25 – $60.08
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $1.4B · P/B 3.62 · P/S 0.91.

Company News

3 captured
8-K filing — PHIBRO ANIMAL HEALTH CORP (PAHC)SEC EDGAR · Jul 28, 2026, 8:16 PM
Phibro Animal Health Appoints Daniel (Dani) Bendheim As CEO And President Effective July 1, 2026Benzinga · Jun 26, 2026, 9:15 PM
Citigroup Maintains Neutral on Phibro Animal Health, Lowers Price Target to $44Benzinga · May 14, 2026, 7:02 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock